Freshly Printed - allow 10 days lead
Couldn't load pickup availability
Medicinal Chemistry of Anticancer Drugs
Revised and updated resource that bridges the gap between elementary sources and primary literature on the mechanisms and reactivity of antitumor drugs and agents
Carmen Avendaño (Author), J. Carlos Menéndez (Author)
9780128185490, Elsevier Science
Paperback, published 28 April 2023
1060 pages
23.5 x 19 x 6.3 cm, 1 kg
This third edition of Medicinal Chemistry of Anticancer Drugs, provides an updated resource for students and researchers from the point of view of medicinal chemistry and drug design, focusing on the mechanism of action of antitumor drugs from the molecular level, and on the relationship between chemical structure and chemical and biochemical reactivity of antitumor agents. Antitumor chemotherapy is a very active field of research, and a huge amount of information on the topic is generated every year. This new edition includes updated sections on the hot topic of cancer immunotherapy, cancer polypharmacology, multitargeted cancer therapy, medicinal chemistry of cancer diagnosis, theranostic anticancer agents, and pre-mRNA processing in cancer. Although many books are available that deal with clinical aspects of cancer chemotherapy, this book provides a unique and valuable perspective from the point of view of medicinal chemistry and drug design. It will be useful to undergraduate and postgraduate students of medicinal chemistry, pharmacology, biological chemistry, pharmacy and other health sciences. Researchers and practitioners will find a comprehensive treatment of the topic and a large number of references to reviews and the primary literature.
1. Introduction
2. Antimetabolites
3. Anticancer Drugs That Modulate Hormone Action
4. Anticancer strategies involving radical species
5. DNA Alkylating Agents
6. Anticancer Drugs That Interact with the DNA Minor Groove
7. Anticancer Drugs acting by DNA intercalation and topoisomerase inhibition
8. Epigenetic Therapy of Cancer
9. Anticancer Drugs Targeting Tubulin and Microtubules
10. Drugs Tacting on signaling pathways, part 1: Tirosine kinase inhibitors
11. Anticancer drugs acting on signaling pathways, part 2
12. Protein degradation-based cancer therapy
13. Cancer immunotherapy
14. Miscellaneous small-molecule and biological approaches to cancer therapy
15. Drug Targeting in Anticancer Chemotherapy
16. Drugs That Modulate Resistance to Anticancer Agents
17. Cancer Chemoprevention
Subject Areas: Biochemistry [PSB], Organic chemistry [PNN], Pharmacology [MMG], Pharmaceutical industries [KNDP]
